Janux Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +2,288.4% | +2,242.1% | -4.2% | +4.5% | +179.0% | -5.1% | |
| – | +2,341.0% | +2,247.3% | -11.8% | +5.1% | +196.0% | -5.6% | |
| – | +1,087.4% | +355.4% | +44.5% | -62.7% | +2,142.2% | -87.8% | |
| – | +1,087.4% | +4,699.2% | -12.8% | +5.2% | +198.0% | -5.7% | |
| – | – | -97.5% | +250.0% | +214.3% | +144.6% | +19.5% | |
| – | – | – | – | – | – | – | |
| – | +638.1% | +930.3% | +343.7% | – | – | – | |
| – | +257.8% | -56.3% | +220.6% | -16.7% | +7.4% | +30.9% | |
| – | -31.3% | +302.3% | +29.0% | -21.0% | +34.0% | +43.2% | |
| – | -81.2% | -74.2% | +293.3% | +98.8% | +15.3% | +36.8% | |
| – | +60.3% | +474.3% | -12.2% | +12.3% | +66.1% | +23.5% | |
| – | – | – | -12.4% | +7.4% | +197.0% | -6.4% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | -0.9% | +0.5% | +6.1% | +22.1% | +15.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.